Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients with stable coronary artery disease, it remains unclear whether an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) is superior to optimal medical therapy alone in reducing the risk of cardiovascular events. METHODS: We conducted a randomized trial involving 2287 patients who had objective evidence of myocardial ischemia and significant coronary artery disease at 50 U.S. and Canadian centers. Between 1999 and 2004, we assigned 1149 patients to undergo PCI with optimal medical therapy (PCI group) and 1138 to receive optimal medical therapy alone (medical-therapy group). The primary outcome was death from any cause and nonfatal myocardial infarction during a follow-up period of 2.5 to 7.0 years (median, 4.6). RESULTS: There were 211 primary events in the PCI group and 202 events in the medical-therapy group. The 4.6-year cumulative primary-event rates were 19.0% in the PCI group and 18.5% in the medical-therapy group (hazard ratio for the PCI group, 1.05; 95% confidence interval [CI], 0.87 to 1.27; P=0.62). There were no significant differences between the PCI group and the medical-therapy group in the composite of death, myocardial infarction, and stroke (20.0% vs. 19.5%; hazard ratio, 1.05; 95% CI, 0.87 to 1.27; P=0.62); hospitalization for acute coronary syndrome (12.4% vs. 11.8%; hazard ratio, 1.07; 95% CI, 0.84 to 1.37; P=0.56); or myocardial infarction (13.2% vs. 12.3%; hazard ratio, 1.13; 95% CI, 0.89 to 1.43; P=0.33). CONCLUSIONS: As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy. (ClinicalTrials.gov number, NCT00007657 [ClinicalTrials.gov].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended (Fig. 10.5), in part because these high-risk people should already be receiving intensive medical therapy-an approach that provides benefits similar to those of invasive revascularization (208,209).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [208]
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended, in part because these high-risk people should already be receiving intensive medical therapy—an approach that provides benefits similar to those of invasive revascularization (197,198).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [197]
In the citing paper
“OMT with risk modification remains the foundation of management in patients with T2DM and CAD.263,264”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [264]
In the citing paper
“these high-risk patients should already be receiving intensive medical therapy -an approach that provides benefi t similar to invasive revascularization (172,173).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [172]
In the citing paper
“The screening of asymptomatic patients remains controversial, especially as intensive medical therapy indicated in diabetic patients at high risk for CVD has an increasing evidence base for providing equal outcomes to invasive revascularization, including in diabetic patients (222).”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [222]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Self-citationThe SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Keeley, E. C., Boura, J. A., & Grines, C. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12113-7 · Cited by 4,361
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Research works printed but not linked: 2
- 1994, Lancet, 344, 1383
- 10.2307/2281868 · doi:10.2307/2281868 · Paper page
Cited by
Items 401–500 of 1,002
Roukoz, H., Bavry, A. A., Sarkees, M. L., Mood, G. R., Kumbhani, D. J., Rabbat, M., & Bhatt, D. L. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.12.019 · Cited by 89
Guideline For Stable Coronary Artery Disease
César, L. A. M., Ferreira, J., Armaganijan, D., Gowdak, L. H. W., Mansur, A. D. P., Bodanese, L., Sposito, A. C., Sousa, A. C., Aj, C., Markman, B., et al. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2014s004 · Cited by 124
Predictors of Inaccurate Coronary Arterial Stenosis Assessment by CT Angiography
Yan, R. T., Miller, J. M., Rochitte, C. E., Dewey, M., Niinuma, H., Clouse, M. E., Vavere, A. L., Brinker, J., Lima, J. A. C., & Arbab‐Zadeh, A. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2013.02.011 · Cited by 89
Fu, M., Sun, C., Lin, Y., Wang, C., Wu, C., Ko, S., Chua, S. O., Sheu, J., Chiang, C.-H., Shao, P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024342 · Cited by 88
“Despite the advance in pharmacological therapy [4,5], mature technique of coronary artery bypass grafting (CABG) [6,7], newly developed instrument-supported percutaneous coronary intervention (PCI) [8,9] for restoring myocardial perfusion, and current guideline focused on management strategy [10], restenosis due to pr…”
BackgroundOhman, E. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1502240 · Cited by 110
Aronson, D., & Edelman, E. R. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9135-3 · Cited by 88
“The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial also showed that percutaneous intervention with optimal medical therapy was no better than optimal medical therapy alone for patients with stable CAD in general and for a subgroup of patients with DM (34% of patients enrol…”
Outcomes Research: Generating Evidence for Best Practice and Policies
Krumholz, H. M. (2008) · Circulation · doi:10.1161/circulationaha.107.690917 · Cited by 90
Kloner, R. A., & CHAITMAN, B. R. (2016) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248416679733 · Cited by 86
“However, this benefit was no longer seen at 5 years.(14) There have been some subgroups of high-risk patients in stable ischemic heart disease clinical trials that have had better clinical outcomes, free of major adverse cardiovascular events, with revascularization as recently reviewed,(15) including patients with le…”
BackgroundSelf-citationKim, H. Y., Lim, H., Doh, J., Nam, C., Shin, E., Koo, B., Yoon, M., Tahk, S., Kang, D. K., Song, Y. B., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.04.008 · Cited by 87
Glossary of terms related to pharmaceutics (IUPAC Recommendations 2009)
Breuer, E., Chorghade, M. S., Fischer, J., & Golomb, G. (2009) · Pure and Applied Chemistry · doi:10.1351/pac-rec-04-10-14 · Cited by 85
Conti, C. R., Bavry, A. A., & Petersen, J. W. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.07.050 · Cited by 84
Yang, S., Koo, B., Hoshino, M., Lee, J. M., Murai, T., Park, J., Zhang, J., Hwang, D., Shin, E., Doh, J., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.08.025 · Cited by 94
Chronic stable coronary artery disease: drugs vs. revascularization
Simoons, M. L., & Windecker, S. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp605 · Cited by 97
Noninvasive Imaging to Assess Atherosclerotic Plaque Composition and Disease Activity
Daghem, M., Bing, R., Fayad, Z. A., & Dweck, M. R. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.03.033 · Cited by 97
Sarno, G., Decramer, I., Vanhoenacker, P. K., Bruyne, B. D., Hamilos, M. I., Cuisset, T., Wyffels, E., Bartúnek, J., Heyndrickx, G. R., & Wijns, W. C. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.03.009 · Cited by 83
Ko, D. T., Tu, J. V., Samadashvili, Z., Guo, H., Alter, D. A., Cantor, W. J., & Hannan, E. L. (2010) · Circulation · doi:10.1161/circulationaha.109.926881 · Cited by 83
Role of Coronary Vasoconstriction in Ischemic Heart Disease and Search for Novel Therapeutic Targets
Maseri, A., Beltrame, J. F., & Shimokawa, H. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0033 · Cited by 83
Sex-Specific Considerations in the Presentation, Diagnosis, and Management of Ischemic Heart Disease
Nussbaum, S. S., Henry, S. A., Yong, C. M., Daugherty, S. L., Mehran, R., & Poppas, A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.11.065 · Cited by 99
The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy
Schuett, K. A., Marx, N., & Lehrke, M. (2023) · Circulation Research · doi:10.1161/circresaha.122.321748 · Cited by 100
Ghadri, J. R., Pazhenkottil, A. P., Nkoulou, R. N., Goetti, R. P., Buechel, R. R., Husmann, L., Herzog, B. A., Wolfrum, M., Wyss, C. A., Templin, C., et al. (2011) · Heart · doi:10.1136/hrt.2010.217281 · Cited by 88
“This, however, reflects common daily practice in many coronary catheterization laboratories(45) and is in line with recent randomized trials evaluating coronary revascularization, like the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation), BARI 2D (Bypass Angioplasty Revascularizat…”
ResultCardiovascular risk assessment in kidney transplantation
Hart, A., Weir, M. R., & Kasiske, B. L. (2014) · Kidney International · doi:10.1038/ki.2014.335 · Cited by 86
Recent Advances in Preventive Cardiology and Lifestyle Medicine: A Themed Series
Franklin, B. A., & Cushman, M. (2011) · Circulation · doi:10.1161/circulationaha.110.981613 · Cited by 96
Medicare Services Provided by Cardiologists in the United States: 1999–2008
Andrus, B. W., & Welch, H. G. (2012) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.961813 · Cited by 81
Exercise-Induced Myocardial Ischemia Detected by Cardiopulmonary Exercise Testing
Chaudhry, S., Arena, R. A., Wasserman, K., Hansen, J. E., Lewis, G. D., MYERS, J. N., Chronos, N. A. F., & Boden, W. E. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.10.034 · Cited by 81
Self-citationNarula, J., & Strausś, H. W. (2007) · Nature Medicine · doi:10.1038/nm0507-532 · Cited by 81
Prognostic Value of Exercise Capacity in Patients With Coronary Artery Disease
Hung, R. K., Al-Mallah, M. H., McEvoy, J. W., Whelton, S. P., Blumenthal, R. S., Nasir, K., Schairer, J. R., Brawner, C. A., Alam, M., Keteyian, S. J., et al. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.07.011 · Cited by 92
Schouten, O., van Kuijk, J., Flu, W., Winkel, T. A., Welten, G. M. J. M., Boersma, E. H., Verhagen, H. J. M., Bax, J. J., & Poldermans, D. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.12.018 · Cited by 87
Bastarrika, G., Lee, Y. S., Huda, W., Ruzsics, B., Costello, P., & Schoepf, U. J. (2009) · Radiology · doi:10.1148/radiol.2532081738 · Cited by 82
Finding the Gatekeeper to the Cardiac Catheterization Laboratory
Marwick, T. H., Cho, I., Hartaigh, B. Ó., & Min, J. K. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.060 · Cited by 87
The Pragmatist's Guide to Comparative Effectiveness Research
Chandra, A., Jena, A. B., & Skinner, J. (2011) · The Journal of Economic Perspectives · doi:10.1257/jep.25.2.27 · Cited by 87
“For this group, accounting for about one-third of all PCI procedures, clinical trials have found no mortality benefit and little (and transitory) symptom benefit of PCI relative to drug therapy alone (Boden et al., 2007; Weintraub et al., 2008).”
Pazhenkottil, A. P., Nkoulou, R. N., Ghadri, J. R., Herzog, B. A., Kuest, S. M., Husmann, L., Wolfrum, M., Goetti, R. P., Buechel, R. R., Gaemperli, O., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr232 · Cited by 79
“appropriate therapy for patients with chronic stable CAD as, for example, seen in the COURAGE trial.(29) This is further evidenced by the fact that even in the group with matched findings, not all”
ResultLu, M. T., Meyersohn, N. M., Mayrhofer, T., Bittner, D. O., Emami, H., Puchner, S. B., Foldyna, B., Mueller, M. E., Hearne, S. E., Yang, C., et al. (2017) · Radiology · doi:10.1148/radiol.2017172181 · Cited by 83
Journey in Evolution of Nuclear Cardiology
Dilsizian, V., & Taillefer, R. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.10.006 · Cited by 79
Percutaneous coronary intervention for small vessel coronary artery disease
Biondi‐Zoccai, G., Moretti, C., Abbate, A., & Sheiban, I. (2010) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2009.04.007 · Cited by 79
Eisen, A., Bhatt, D. L., Steg, P. G., Eagle, K. A., Goto, S., Guo, J., Smith, S. C., Ohman, E. M., Scirica, B. M., & the REACH Registry Investigators (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004080 · Cited by 83
“Prior studies have demonstrated that the major bene fi t of optimal medical therapy or revascularization in patients with stable CAD is the relief of anginal symptoms rather than a reduction in cardiovascular death or MI. 13,20,21 24 The ongoing International Study of Comparative Health Effectiveness With Medical and I…”
BackgroundInfluentialFerrari, R., Ford, I., Fox, K. M., Challeton, J. P., Correges, A., Tendera, M., Widimský, P., & Danchin, N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31790-6 · Cited by 82
Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How
Liga, R., Colli, A., Taggart, D. P., Boden, W. E., & Caterina, R. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.026943 · Cited by 92
Self-citationLevin, D. C., & Rao, V. M. (2008) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2008.01.025 · Cited by 78
‘Bench To Behavior’: Translating Comparative Effectiveness Research Into Improved Clinical Practice
Avorn, J., & Fischer, M. A. (2010) · Health Affairs · doi:10.1377/hlthaff.2010.0696 · Cited by 89
Profile of Inpatient Operating Room Procedures in US Hospitals in 2007
Elixhauser, A. (2010) · Archives of Surgery · doi:10.1001/archsurg.2010.269 · Cited by 78
Hoenig, M. R., Aroney, C. N., & Scott, I. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004815.pub3 · Cited by 79
Kang, S., Ahn, J., Song, H., Kim, W.-J., Lee, J., Park, D., Yun, S., Lee, S., Kim, Y., Lee, C. W., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.11.024 · Cited by 77
Wijeysundera, H. C., Norris, C. M., Fefer, P., Galbraith, P. D., Knudtson, M. L., Wolff, R., Wright, G. A., Strauss, B. H., & Ko, D. T. (2014) · EuroIntervention · doi:10.4244/eijv9i10a197 · Cited by 80
Self-citationNg, M., Yong, A. S. C., Ho, M. Y., Shah, M., Chawantanpipat, C., O'Connell, R. L., KEECH, A. C., Kritharides, L., & Fearon, W. F. (2012) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.969048 · Cited by 77
Management of stable coronary artery disease
Pfisterer, M. E., Zellweger, M. J., & Gersh, B. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60168-7 · Cited by 79
Cardiovascular Disease in the Elderly
Schwartz, J. B., & Zipes, D. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00080-9 · Cited by 79
The Optimal Imaging Strategy for Patients With Stable Chest Pain: A Cost-Effectiveness Analysis
Genders, T. S. S., Petersen, S. E., Pugliese, F., Dastidar, A. G., Fleischmann, K. E., Nieman, K., & Hunink, M. G. M. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0027 · Cited by 85
Hannan, E. L., Samadashvili, Z., Cozzens, K. S., Walford, G. D., Jacobs, A. K., Holmes, D. R., Stamato, N. J., Gold, J. P., Sharma, S., Venditti, F. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.071811 · Cited by 79
Shah, R. V., Heydari, B., Coelho‐Filho, O. R., Murthy, V. L., Abbasi, S. A., Feng, J. H., Pencina, M. J., Neilan, T. G., Meadows, J. L., Francis, S. A., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001430 · Cited by 77
Treatment of Angina: Where Are We?
Balla, C., Pavasini, R., & Ferrari, R. (2018) · Cardiology · doi:10.1159/000487936 · Cited by 94
Possible link between large artery stiffness and coronary flow velocity reserve
Saito, M., Okayama, H., Nishimura, K., Ogimoto, A., Ohtsuka, T., Inoue, K., Hiasa, G., Sumimoto, T., & Higaki, J. (2007) · Heart · doi:10.1136/hrt.2007.126128 · Cited by 83
Rossi, A., Uitterdijk, A., Dijkshoorn, M. L., Klotz, E., Dharampal, A., van Straten, M., van der Giessen, W. J., Mollet, N., van Geuns, R., Krestin, G. P., et al. (2012) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jes150 · Cited by 76
Kataruka, A., Maynard, C. C., Kearney, K. E., Mahmoud, A., Bell, S. M., Doll, J. A., McCabe, J. M., Bryson, C., Gurm, H. S., Jneid, H. M., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015317 · Cited by 75
“1–3 In addition, the proportion of elderly patients and prevalence of medical comorbidities among patients treated with coronary revascularization have increased in the contemporary era.”
Diagnostic-Therapeutic Cascade Revisited
Lucas, F. L., Siewers, A. E., Malenka, D. J., & Wennberg, D. E. (2008) · Circulation · doi:10.1161/circulationaha.108.789446 · Cited by 75
Challenges in the Medical Management of Symptomatic Intracranial Stenosis in an Urban Setting
Sangha, R. S., Naidech, A. M., Corado, C., Ansari, S. A., & Prabhakaran, S. (2017) · Stroke · doi:10.1161/strokeaha.116.016254 · Cited by 77
Sequential proteome alterations during genesis and progression of colon cancer
Gustafsson, M., Bruch, H.-P., Franz�n, B., Ried, T., Bergmann, T., Auer, G., J�rnvall, H., Roblick, U. J., Hirschberg, D., Habermann, J. K., et al. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4049-4 · Cited by 81
Diagnostic Accuracy and Clinical Utility of Noninvasive Testing for Coronary Artery Disease
Weustink, A. C., Mollet, N. R., Neefjes, L. A., Meijboom, W. B., Galema, T. W., van Mieghem, C. A. G., Kyrzopoulous, S., Eu, R. N., Nieman, K., Cademartiri, F., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-10-201005180-00003 · Cited by 73
Bansilal, S., Bonaca, M. P., Cornel, J. H., Storey, R. F., Bhatt, D. L., Steg, P. G., Im, K., Murphy, S. A., Angiolillo, D. J., Kiss, R. G., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.050 · Cited by 76
“It has become clear that background medical therapy plays a critical role with regard to risk reduction in high-risk patients (14).”
BackgroundAbou‐Chebl, A., & Steinmetz, H. (2012) · Stroke · doi:10.1161/strokeaha.111.641563 · Cited by 74
Coronary Artery Disease Is Under-diagnosed and Under-treated in Advanced Lung Disease
Reed, R. M., Eberlein, M., Girgis, R. E., Hashmi, S., Iacono, A., Jones, S., Netzer, G., & Scharf, S. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.05.018 · Cited by 75
Use of Nicorandil in Cardiovascular Disease and Its Optimization
Horinaka, S. (2011) · Drugs · doi:10.2165/11592300-000000000-00000 · Cited by 74
“However, in recent studies, PCI did not always improve long-term outcome in patients with stable angina who were undergoing optimal medical treatment.([1-4]) The importance of drug treatment is therefore being reconsidered.”
ResultBoden, W. E., O’Rourke, R. A., Teo, K. K., Maron, D. J., Hartigan, P. M., Sedlis, S. P., Dada, M. R., Labedi, M., Spertus, J. A., Kostuk, W. J., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.02.059 · Cited by 74
Self-citationTu, L., Pan, C., Wei, X., Yan, L., Liu, Y., Fan, J., Mu, H., Li, Q., Li, L., Zhang, Y., et al. (2013) · Microcirculation · doi:10.1111/micc.12074 · Cited by 75
“Although PCI can restore the blood flow in myocardium rapidly, it does not reduce the risk of serious heart events because of reperfusion injury [1,3].”
BackgroundAngina after percutaneous coronary intervention: The need for precision medicine
Niccoli, G., Montone, R. A., Lanza, G. A., & Crea, F. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.07.105 · Cited by 79
Lazzeri, C., Sori, A., Chiostri, M., Gensini, G. F., & Valente, S. (2009) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32832a235c · Cited by 75
Min, J. K., Berman, D. S., Dunning, A., Achenbach, S. S., Al-Mallah, M. H., Budoff, M. J., Cademartiri, F., Callister, T. Q., Chang, H., Cheng, V., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs315 · Cited by 76
Self-citationRandomized Trials Versus Common Sense and Clinical Observation
Fanaroff, A. C., Califf, R. M., Harrington, R. A., Granger, C. B., McMurray, J. J. V., Patel, M. R., Bhatt, D. L., Windecker, S., Hernandez, A. F., Gibson, C. M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.069 · Cited by 80
Thomas, G. S., Vörös, S., McPherson, J., Lansky, A. J., Winn, M. E., Bateman, T. M., Elashoff, M. R., Lieu, H. D., Johnson, A. M., Daniels, S. E., et al. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.964015 · Cited by 73
PET: Is myocardial flow quantification a clinical reality?
Saraste, A., Kajander, S. A., Han, C., Nesterov, S. V., & Knuuti, J. M. (2012) · Journal of Nuclear Cardiology · doi:10.1007/s12350-012-9588-8 · Cited by 72
Outcomes from a Multiple Risk Factor Diabetes Self-Management Trial for Latinas: ¡Viva Bien!
Toobert, D. J., Strycker, L. A., Barrera, M., Osuna, D., King, D. K., & Glasgow, R. E. (2011) · Annals of Behavioral Medicine · doi:10.1007/s12160-010-9256-7 · Cited by 72
Derdeyn, C. P., & Chimowitz, M. I. (2007) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2007.05.001 · Cited by 80
Goff, S. L., Mazor, K. M., Ting, H. H., Kleppel, R., & Rothberg, M. B. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.3328 · Cited by 76
Lambrakis, K., French, J. K., Scott, I. A., Briffa, T. G., Brieger, D. B., Farkouh, M. E., White, H. D., Chuang, M.-Y. A., Tiver, K. D., Quinn, S. J., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.09.016 · Cited by 73
Berman, D. S., Shaw, L. J., Hachamovitch, R., Friedman, J. D., Polk, D. M., Hayes, S. W., Thomson, L., Germano, G., Wong, N. D., Kang, X., et al. (2006) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2006.08.002 · Cited by 77
Self-citationTimbie, J. W., Fox, D. S., Busum, K. R. V., & Schneider, E. C. (2012) · Health Affairs · doi:10.1377/hlthaff.2012.0150 · Cited by 70
Evolving Management Paradigm for Stable Ischemic Heart Disease Patients
Boden, W. E., Marzilli, M., Crea, F., Mancini, G. B. J., Weintraub, W., Taqueti, V. R., Pepine, C. J., Escaned, J., Al-Lamee, R. K., Gowdak, L. H. W., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.08.814 · Cited by 82
Self-citationde Labriolle, A., Bonello, L., Roy, P. K., Lemesle, G., Steinberg, D. H., Xue, Z., Kaneshige, K., Suddath, W. O., Satler, L. F., Kent, K. M., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.06.059 · Cited by 71
Arbab‐Zadeh, A. (2012) · Heart International · doi:10.4081/hi.2012.e2 · Cited by 76
Brooks, M. M., Chaitman, B. R., Nesto, R. W., Hardison, R. M., Feit, F., Gersh, B. J., Krone, R. J., Sako, E. Y., Rogers, W. J., Garber, A. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.092973 · Cited by 70
Self-citationGada, H., Kirtane, A. J., Kereiakes, D. J., Bangalore, S., Moses, J. W., Généreux, P., Mehran, R., Dangas, G., Leon, M. B., & Stone, G. W. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.556 · Cited by 70
Clinical Utility of Regadenoson for Assessing Fractional Flow Reserve
Nair, P. K., Marroquin, O. C., Mulukutla, S. R., Khandhar, S., Gulati, V. K., Schindler, J. T., & Lee, J. S. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2011.07.011 · Cited by 70
Uetani, T., Amano, T., Kunimura, A., Kumagai, S., Ando, H., Yokoi, K., Yoshida, T., Kato, B., Kato, M., Marui, N., et al. (2010) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2009.09.016 · Cited by 70
Ghimire, G., Spiro, J. R., Kharbanda, R. K., Roughton, M., Barlis, P., Mason, M. J., Ilsley, C. D. J., Mario, C. D., Erbel, R. M., Waksman, R., et al. (2009) · EuroIntervention · doi:10.4244/jv4i4a82 · Cited by 70
Arteriosclerosis: facts and fancy
Fishbein, M. C., & Fishbein, G. A. (2015) · Cardiovascular Pathology · doi:10.1016/j.carpath.2015.07.007 · Cited by 82
“Very few events were due to progression of lesions that had less than 50% diameter narrowing [63].”
BackgroundPCI Choice Decision Aid for Stable Coronary Artery Disease: A Randomized Trial
Coylewright, M., Dick, S., Zmolek, B., Askelin, J., Hawkins, E., Branda, M., Inselman, J. W., Zeballos-Palacios, C., Shah, N. D., Hess, E. P., et al. (2016) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.116.002641 · Cited by 70
Gaemperli, O., Husmann, L., Schepis, T., Koepfli, P., Valenta, I., Jenni, W., Alkadhi, H., Lüscher, T. F., & Kaufmann, P. A. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp304 · Cited by 68
“In stable CAD, the debate on the role of elective percutaneous coronary intervention (PCI) is highly controversial.(4,5) Guidelines recommend proof of ischemia prior to elective revascularization of coronary stenoses,(2,4,6) and several reports have demonstrated that PCI fails to improve prognosis in patients with sta…”
BackgroundRenal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?
Lüscher, T. F., & Mahfoud, F. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu195 · Cited by 76
Percutaneous coronary intervention for stable coronary artery disease
Al-Lamee, R. K., Nowbar, A. N., & Francis, D. P. (2018) · Heart · doi:10.1136/heartjnl-2017-312755 · Cited by 69
Endothelial cell dysfunction in cardiac disease: driver or consequence?
Allbritton‐King, J. D., & García‐Cardeña, G. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1278166 · Cited by 79
Bradley, S. M., Bohn, C. M., Malenka, D. J., Graham, M. M., Bryson, C. L., McCabe, J. M., Curtis, J. P., Lambert-Kerzner, A., & Maynard, C. (2015) · Circulation · doi:10.1161/circulationaha.114.015156 · Cited by 68
Increasing rates of angioplasty versus bypass surgery in Canada, 1994-2005
Hassan, A., Newman, A. M., Ko, D. T., Rinfret, S., Hirsch, G. M., Ghali, W. A., & Tu, J. V. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.06.052 · Cited by 69
Priebe, H.-J. (2011) · British Journal of Anaesthesia · doi:10.1093/bja/aer121 · Cited by 72
Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending
Cutler, D., Skinner, J., Stern, A. D., & Wennberg, D. E. (2013) · National Bureau of Economic Research · doi:10.3386/w19320 · Cited by 104
Quality Improvement: Science and Action
Ting, H. H., Shojania, K. G., Montori, V. M., & Bradley, E. H. (2009) · Circulation · doi:10.1161/circulationaha.108.768895 · Cited by 68
Challenging Issues in Clinical Trial Design
Pocock, S., Clayton, T. C., & Stone, G. W. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.051 · Cited by 77
Enfermedad cardiovascular en el anciano
Jackson, C. F., & WENGER, N. K. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.05.001 · Cited by 95
Autologous CD34 + Cell Therapy for Refractory Angina: 2-Year Outcomes from the ACT34-CMI Study
Henry, T. D., Schaer, G. L., Traverse, J. H., Povsic, T. J., Davidson, C. J., Lee, J. S., Costa, M. A., Bass, T. A., Mendelsohn, F. O., Fortuin, F. D., et al. (2016) · Cell Transplantation · doi:10.3727/096368916x691484 · Cited by 68
Comparative effectiveness research: what kind of studies do we need?
Concato, J., Peduzzi, P. N., Huang, G. D., O’Leary, T. J., & Kupersmith, J. (2010) · PubMed · Cited by 68
Innovative Practice, Clinical Research, and the Ethical Advancement of Medicine
Earl, J. (2019) · The American Journal of Bioethics · doi:10.1080/15265161.2019.1602175 · Cited by 73
He, K., Yan, L., Pan, C., Liu, Y., Cui, Y., Hu, B., Chang, X., Li, Q., Sun, K., Mao, X.-W., et al. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00259.2014 · Cited by 68
Metadata
- Authors
- Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., Chaitman, B. R., Shaw, L., Gosselin, G., Nawaz, S., Title, L. M., Gau, G., Blaustein, A. S., Booth, D. C., Bates, E. R., Spertus, J. A., Berman, D. S., Mancini, G. B. J., & Weintraub, W. S.
- Affiliations
- VA Western New York Healthcare System (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-12
- Volume
- 356
- Issue
- 15
- Pages
- 1503-1516
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2160414137
- Cited by
- 4,699
- References
- 49
- Citations by year
- 2026: 111 · 2025: 142 · 2024: 150 · 2023: 166 · 2022: 197 · 2021: 255 · 2020: 282 · 2019: 202 · 2018: 227 · 2017: 211 · 2016: 276 · 2015: 263 · 2014: 295 · 2013: 309 · 2012: 322
- FWCI
- 315.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- optimal medical therapy, percutaneous coronary intervention, stable coronary artery disease, myocardial ischemia, cardiovascular events, myocardial infarction, mortality, lifestyle intervention, coronary artery disease
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angina Pectoris, Angiotensin-Converting Enzyme Inhibitors, Anticholesteremic Agents, Antihypertensive Agents, Combined Modality Therapy, Coronary Disease, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Risk Factors, Angioplasty, Balloon, Coronary, Proportional Hazards Models, Stroke, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.